Lower riskDrug recall · FDA · Published July 5, 2025
FDC Limited Timolol Ophthalmic Solution 0.5% Recall: Cap Stuck in Bottle Nozzle
FDC Limited recalls 5mL Timolol Maleate Ophthalmic Solution bottles due to cap getting stuck in the bottle nozzle. Rx only product with specific lot number and expiration date.
“FDC Limited Timolol Ophthalmic Solution 0.5% Recall: Cap Stuck in Bottle Nozzle.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32002-fdc-limited-timolol-ophthalmic-solution-0-5-recall-cap-stuck. Based on FDA recall #D-0543-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0543-2025%22&limit=1).
The FDA announced on July 5, 2025, that FDC Limited voluntarily recalled Timolol Maleate Ophthalmic Solution USP due to a defective container hazard. The spike of the cap can become lodged in the nozzle, preventing proper delivery of the medication.
Distributed by: Rising Pharmaceuticals Inc, New Jersey
Units affected: 154,176 bottles
The hazard
The recall involves a defective container where the spike of the cap becomes lodged in the nozzle of the product bottle. This defect prevents users from getting the solution out of the bottle.
Context
GovInfoNow's records show FDC Limited has had 10 other recalls since April 25, 2024. Recent similar issues include a March 11, 2025 recall for Ciprofloxacin Ophthalmic Solution and a Jan. 23, 2025 recall for Timolol Ophthalmic Solution 0.5%, both citing caps stuck in nozzles. Other recent recalls of similar products include Micro Labs Dorzolamide/Timolol Eye Drops (July 22, 2026) and Apotex Desmopressin Nasal Spray (April 8, 2026).
How to tell if you have this one
Check for 5mL bottles labeled Timolol Maleate Ophthalmic Solution USP 0.5%, manufactured by FDC Limited, with lot number 083L061 and expiration date 11/2025.
Brand
FDC Limited
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number 083L061 and expiration date 11/2025 on the bottle label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “U.S Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 32 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0543-2025 (July 5, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0543-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.